Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations

Human Molecular Genetics

Volumn 16, Issue 11, 2007, Pages 1343-1350

  Meirhaeghe, Aline ^a,j,k   Sandhu, Manjinder S ^b,c   McCarthy, Mark I ^d   de Groote, Pascal ^e   Cottel, Dominique ^a   Arveiler, Dominique ^f   Ferrières, Jean ^a   Groves, Christopher J ^d   Hattersley, Andrew T ^g   Hitman, Graham A ^h   Walker, Mark ⁱ   Wareham, Nicholas J ^c   Amouyel, Philippe ^a  

^a INSERM   (France)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d CHURCHILL HOSPITAL   (United Kingdom)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f UNIVERSITÉ DE STRASBOURG   (France)

^g PENINSULA MEDICAL SCHOOL   (United Kingdom)

^h QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

ⁱ NEWCASTLE UNIVERSITY   (United Kingdom)

^j INSTITUT PASTEUR DE LILLE   (France)

^k UNIV LILLE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; GLUCOSE;

ANIMAL CELL; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VOLUME; CONTROLLED STUDY; DISEASE ASSOCIATION; ENERGY METABOLISM; FRANCE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; LIPOLYSIS; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPORTER GENE;

EID: 34447339123     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm084     Document Type: Article

References (18)

1. Sarzani, R., Dessi-Fulgheri, P., Paci, V.M., Espinosa, E. and Rappelli, A. (1996) Expression of natriuretic peptide receptors in human adipose and other tissues. J. Endocrinol. Invest., 19, 581-585.
2. Levin, E.R., Gardner, D.G. and Samson, W.K. (1998) Natriuretic peptides. N. Engl. J. Med., 339, 321-328.
3. Sengenes, C., Berlan, M., De Glisezinski, I., Lafontan, M. and Galitzky, J. (2000) Natriuretic peptides: A new lipolytic pathway in human adipocytes. FASEB J., 14, 1345-1351.
4. Mehra, M.R., Uber, P.A., Park, M.H., Scott, R.L., Ventura, H.O., Harris, B.C. and Frohlich, E.D. (2004) Obesity and suppressed B-type natriuretic peptide levels in heart failure. J. Am. Coll. Cardiol., 43, 1590-1595.
5. Wang, T.J., Larson, M.G., Levy, D., Benjamin, E.J., Leip, E.P., Wilson, P.W. and Vasan, R.S. (2004) Impact of obesity on plasma natriuretic peptide levels. Circulation, 109, 594-600.
6. McCord, J., Mundy, B.J., Hudson, M.P., Maisel, A.S., Hollander, J.E., Abraham, W.T., Steg, P.G., Omland, T., Knudsen, C.W., Sandberg, K.R. and McCullough, P.A. (2004) Relationship between obesity and B-type natriuretic peptide levels. Arch. Intern. Med., 164, 2247-2252.
7. Galitzky, J., Sengenes, C., Thalamas, C., Marques, M.A., Senard, J.M., Lafontan, M. and Berlan, M. (2001) The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men. J. Lipid Res., 42, 536-544.
8. Lim, H.S., Patel, J.V., Nadar, S., Hughes, E.A. and Lip, G.Y. (2005) Comparison of brain natriuretic peptide and left ventricular diastolic function determined by tissue Doppler in patients with diabetes mellitus, patients with hypertension without diabetes, and in healthy subjects. Am. J. Cardiol., 95, 905-908.
9. Magnusson, M., Melander, O., Israelsson, B., Grubb, A., Groop, L. and Jovinge, S. (2004) Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease. Diabetes Care 27, 1929-1935.
10. Wu, A.H., Omland, T., Duc, P., McCord, J., Nowak, R.M., Hollander, J.E., Herrmann, H.C., Steg, P.G., Wold, K.C. and Storrow, A.B. et al. (2004) The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea: An analysis from the Breathing Not Properly Multinational Study. Diabetes Care, 27 2398-2404.
11. Kajita, M., Ezura, Y., Iwasaki, H., Ishida, R., Yoshida, H., Kodaira, M., Suzuki, T., Hosoi, T., Inoue, S. and Shiraki, M. et al. (2003) Association of the -381T/C promoter variation of the brain natriuretic peptide gene with low bone-mineral density and rapid postmenopausal bone loss. J. Hum. Genet., 48, 77-81.
12. The World Health Organization MONICA Project. (1994) Ecological analysis of the association between mortality and major risk factors of cardiovascular disease. Int. J. Epidemiol., 23, 505-516.
13. Dallongeville, J., Delcroix, A.G., Wagner, A., Ducimetiere, P., Ruidavets, J.B., Arveiler, D., Bingham, A., Ferrieres, J., Amouyel, P. and Meirhaeghe, A. (2005) The APOA4 Thr347 → Ser347 polymorphism is not a major risk factor of obesity. Obes. Res., 13, 2132-2138.
14. (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 20, 1183-1197.
15. Mizon-Gerard, F., de Groote, P., Lamblin, N., Hermant, X., Dallongeville, J., Amouyel, P., Bauters, C. and Helbecque, N. (2004) Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunction. Eur. Heart J., 25, 688-693.
16. Rathmann, W., Haastert, B., Icks, A., Giani, G., Hennings, S., Mitchell, J., Curran, S. and Wareham, N.J. (2001) Low faecal elastase 1 concentrations in type 2 diabetes mellitus. Scand. J. Gastroenterol. 36, 1056-1061.
17. Harding, A.H., Day, N.E., Khaw, K.T., Bingham, S., Luben, R., Welsh, A. and Wareham, N.J. (2004) Dietary fat and the risk of clinical type 2 diabetes: The European prospective investigation of Cancer-Norfolk study. Am. J. Epidemiol., 159, 73-82.
18. Groves, C.J., Zeggini, E., Minton, J., Frayling, T.M., Weedon, M.N., Rayner, N.W., Hitman, G.A., Walker, M., Wiltshire, S., Hattersley, A.T. and McCarthy, M.I. (2006) Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes, 55, 2640-2644.